InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（4 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Hively Brad, 首席执行官. Officer active across 2 companies, notably Oncology Institute, Inc.. Cumulatively, 23 filings have been published. Breakdown: 2 buys · 4 sells. Total volume traded: €1.8m. History available since 12 January 2021. The latest transaction was filed on 21 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Hively Brad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
298,853 股@ US$6.51260.29% mcap100.0% 占其流量Common StockSEC:0001079973-26-001175:0
27,108 股0Common StockSEC:0001079973-26-000983:0
13,333 股@ US$3.77195.1% 占其流量Common StockSEC:0001079973-25-001861:0
41,667 股0Common StockSEC:0001553350-25-000143:0
20,221 股@ US$4.068.8% 占其流量Common stockSEC:0000935836-25-000552:0
684,528 股@ US$0.8570.1% 占其流量Common StockSEC:0000935836-25-000416:0
45,280 股@ US$1.041720.1% 占其流量Common StockSEC:0000935836-25-000296:0
标准退出：2025年6月24日 (T+90)
9,056 股@ US$1.04174.0% 占其流量Common StockSEC:0001079973-25-000521:0
标准退出：2025年6月24日 (T+90)
353,450 股0Common stockSEC:0001799191-24-000063:0
44,000 股0Common stockSEC:0001799191-24-000050:0
18,121 股@ US$0.45783.6% 占其流量Common StockSEC:0001799191-24-000015:0
19,526 股@ US$0.57534.8% 占其流量Common StockSEC:0001799191-24-000013:0
42,652 股0Common stockSEC:0001628280-23-042829:0
25,867 股@ US$2.19323.8% 占其流量Common stockSEC:0001628280-23-039913:0
25,000 股@ US$0.859.0% 占其流量Common stockSEC:0001628280-23-039815:0
47,000 股@ US$0.8517.2% 占其流量Common stockSEC:0001628280-23-039192:0
168,512 股0Common stockSEC:0001628280-23-008825:0
9,718 股@ US$2.02788.8% 占其流量Common StockSEC:0001799191-22-000050:0
103,469 股0Common StockSEC:0001799191-22-000032:0
9,718 股@ US$2.02788.8% 占其流量Common StockSEC:0001799191-22-000012:0
108,469 股0Common stockSEC:0001628280-22-007101:0
141,380 股0Common StockSEC:0001104659-21-141460:0
141,380 股0Common StockSEC:0001104659-21-140219:0
23 条申报中的 23 条
About Hively Brad
Hively Brad is Directeur Général and a director of Oncology Institute, Inc. (XNAS). He has 21 filings in total, and across the sampled recent filings between 2021-11-16 and 2025-12-16, the buy and sell amounts are 52470 EUR and 221478 EUR, respectively, with the modal transaction nature listed as Attribution.
